Adenovirus infection after pediatric bone marrow transplantation

Bone Marrow Transplantation

Volumn 23, Issue 3, 1999, Pages 277-282

  Hale, G A ^c   Heslop, H E ^c   Krance, R A ^c   Brenner, M A ^c   Jayawardene, D ^c   Srivastava, D K ^c   Patrick, C C ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c NONE

Author keywords

Adenovirus; Bone marrow transplant; Pediatrics; Total body irradiation

Indexed keywords

ADENOVIRUS; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GASTROENTERITIS; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; VIRUS INFECTION; WHOLE BODY RADIATION;

EID: 0032992434     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701563     Document Type: Article

References (34)

1. Piedra PA. Enterovirus/Adenovirus. In: Patrick CC (ed). Infections in Immunocompromised Infants and Children. 3rd edn. Churchill Livingstone: New York, 1992, pp 662-668.
2. Baum S. Adenovirus. In: Mandell GL, Douglas RG Jr, Bennett JE (eds). Principles and Practices of Infectious Diseases, 3rd edn. Churchill Livingstone: New York, 1990, pp 1185-1190.
3. Hierholzer JC. Adenovirus in the immunocompromised host. Clin Micro Rev 1992; 5: 262-274.
4. Landry ML, Fong CK, Neddermann K et al. Disseminated adenovirus infection in an immunocompromised host. Am J Med 1987; 83: 555-559.
5. Sable AC, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis 1994; 18: 273-284.
6. Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 1989; 4: 35-40.
7. Skinner J, Finlay J, Sondel P, Trigg M. Infectious complications in pediatric patients undergoing transplantation with T lymphocyte-depleted bone marrow. Pediatr Infect Dis J 1986; 5: 319-324.
8. Wasserman R, August C, Plotkin S. Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 1988; 7: 109-115.
9. Miyamura K, Takeyama K, Kojima S et al. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 533-535.
10. Yolken R, Bishop C, Townsend T et al. Infectious gastroenteritis in bone marrow transplant recipients. New Engl J Med 1982; 306: 1009-1012.
11. Londergan T, Walzak M. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation. J Urol 1994; 151: 1013-1014.
12. Johnson PRE, Yin JAL, Morris DJ et al. Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation. Bone Marrow Transplant 1990; 5: 345-347.
13. Ambinder RF, Burns M, Forman M et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 1986; 146: 1400-1401.
14. Liles WC, Cushing H, Jolt S et al. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with ribavirin. Bone Marrow Transplant 1993; 12: 409-412.
15. Krilov LR, Rubin LG, Frogel M et al. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis 1990; 12: 303-307.
16. Niemann TH, Trigg ME, Winick N et al. Disseminated adenoviral infection presenting as acute pancreatitis. Hum Pathol 1993; 24: 1145-1148.
17. Davis D, Henslee PJ, Markesbery WR. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient. Ann Neurol 1988; 23: 385-389.
18. Shields A, Hackman R, Fife K et al. Adenovirus infections in patients undergoing bone-marrow transplantation. New Engl J Med 1985; 312: 529-533.
19. Flomenberg P, Babbitt J, Drobyski W et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775-781.
20. Prentice HG, Brenner MK, Janossy G et al. T depletion using MBG6 and RFT8 monoclonal antibody combination and complement lysis prevents significant acute and chronic GVHD in allogeneic marrow transplants. Exp Hematol 1985; 13 (Suppl. 17): 115-116.
21. Prentice HG, Janossy G, Price-Jones L et al. Depletion of T-lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; 1: 472-476.
22. Patterson J, Prentice HG, Brenner MK et al. Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol 1986; 63: 221-230.
23. Koehler M, Hurwitz CA, Krance RA et al. Xomazyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors. Bone Marrow Transplant 1994; 13: 571-575.
24. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
25. Atkinson K, Horowitz MM, Gale RP et al. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 247-274.
26. Murphy G, Wood D, McRoberts JW et al. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 1993; 149: 565-566.
27. Cassano WF. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 7: 247-248.
28. Hromas R, Clark C, Blanke C et al. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 663-666.
29. Taylor DL, Jeffries DJ, Taylor-Robinson D et al. The susceptibility of adenovirus infection to the anti-cytomegalovirus drug, ganciclovir (DHPG). FEMS Microbiol Lett 1988; 49: 337-341.
30. Dagan R, Schwartz RH, Insel RA et al. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human serum globulin containing a specific neutralizing antibody. Pediatr Infect Dis 1984; 3: 246-251.
31. Rooney CM, Smith CA, Ng CYC et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 1995; 345: 9-13.
32. Heslop HE, Ng CYC, Li C et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene modified virus-specific T lymphocytes. Nature Med 1996; 2: 551-555.
33. Walter EA. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New Engl J Med 1995; 333: 1038-1044.
34. Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994; 84: 1689-1690.